Table 2.

Patient profiles and transplanted SVF information

Subject’s No	Age	Sex	Stage	Aspirated adipose tissue/cc	Harvested SVF volume/cc	Live SVF cells × 106/cc	Injected live cells × 106/48 spot
1	51	M	Class IV	70.2	15.4	1.62	9.55
2	51		Class IV	90	17.0	1.62	7.68
3	54		Class V	80	17.0	0.65	7.68
4	56		Class V	90	17.0	0.69	7.68
5	43	F	Class II	90	14.6	1.01	7.68
6	44		Class II	90	17.0	1.22	7.68
7	48		Class I	90	15.3	1.29	7.68
8	59		Class II	80	17.0	1.32	7,68
9	64		Class III	90	16.0	2.15	7.68

The viability of SVF cells was 95.4 ± 3.6% (range 91.8–99%) before and after needle injection